Last Updated: June 9, 2026

Suppliers and packagers for FENOFIBRIC ACID


✉ Email this page to a colleague

« Back to Dashboard


FENOFIBRIC ACID

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Alembic FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 208705 ANDA Alembic Pharmaceuticals Limited 46708-244-30 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-244-30) 2017-05-15
Alembic FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 208705 ANDA Alembic Pharmaceuticals Limited 46708-244-90 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-244-90) 2017-05-15
Alembic FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 208705 ANDA Alembic Pharmaceuticals Limited 46708-244-91 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-244-91) 2017-05-15
Alembic FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 208705 ANDA Alembic Pharmaceuticals Limited 46708-245-30 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-245-30) 2017-05-18
Alembic FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 208705 ANDA Alembic Pharmaceuticals Limited 46708-245-90 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-245-90) 2017-05-18
Alembic FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 208705 ANDA Alembic Pharmaceuticals Limited 46708-245-91 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (46708-245-91) 2017-05-18
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for FENOFIBRIC ACID

Last updated: April 24, 2026

Suppliers for Fenofibric Acid (API and Key Derivatives)

Fenofibric acid supply is typically handled through (1) API manufacturers (direct sale), (2) contract manufacturers and custom synthesis providers (intermediates to API), and (3) distributors/rep company channels for regional fulfillment. Fenofibric acid also appears as an ingredient supplied in finished-dose forms in some markets, but the commercial “supplier” landscape is dominated by API and intermediate supply.

Which companies supply fenofibric acid API?

Below are established global players that publicly market fenofibric acid (CAS 4465-29-4) in catalog or product-line form and/or support API sourcing via standard commercial channels.

API / bulk chemical catalog supply (global)

Company Typical role What it sells (publicly) Notes
Aarti Industries API/chemicals supplier Fenofibric acid (bulk/API catalog listings) India-based chemical and pharma intermediate/API supplier; sells through B2B channels.
Alfa Aesar (Thermo Fisher Scientific) Distributor/catalog chemical Fenofibric acid Widely used for research-grade and bulk supply via global distribution.
TCI Chemicals Distributor/catalog chemical Fenofibric acid Common catalog supplier across research and bulk channels.
MedChemExpress (MCE) Distributor/catalog chemical Fenofibric acid Offers small-to-mid scale chemical supply through B2B e-commerce.
Cayman Chemical Distributor/catalog chemical Fenofibric acid Common for analytical and reference material supply via catalog channels.
Toronto Research Chemicals (TRC) Distributor/catalog chemical Fenofibric acid Catalog chemical supplier; distribution is via global channels.

API / contract manufacturing and supply-chain roles

Fenofibric acid API supply is often routed through established Asian API and chemical manufacturers plus contract manufacturing relationships. The following are frequently referenced categories in supply procurement for fenofibric acid and closely related fibrate APIs, where sourcing is supported via intermediate-to-API workflows and regulatory documentation.

Supplier type What they do for fenofibric acid supply Buyer impact
API manufacturers (direct) Sell fenofibric acid API in bulk with CoA and typical pharma documentation Lower lead times when in-stock; direct QA/QC documentation available.
Custom synthesis / intermediate-to-API CMOs Make fenofibric acid from contracted routes, often via disclosed or semi-disclosed intermediate supply Useful for qualification programs and constrained capacity.
Regional distributors Stock fenofibric acid (and often request drop-ship or repack) Faster regional logistics; consolidated purchasing.

Which intermediates drive fenofibric acid supply?

Commercial routes rely on availability of the acid and activated intermediate precursors. In practice, procurement often tracks these “upstream” choke points because API supply is sensitive to upstream capacity and regulatory documentation flow.

Fenofibric acid common procurement points in supply chains

  • Fenofibrate-to-fenofibric acid conversion (industry sometimes uses hydrolysis/processing routes when manufacturing or intermediation is optimized)
  • Core aromatic and ester precursor availability (route-specific, depending on manufacturer)
  • Crude acid purification capacity (solvent recovery and crystallization constraints affect lead times)

Distributor channel reality: how procurement typically plays out

For fenofibric acid, procurement usually splits into two tracks:

  1. R&D and analytical demand (small to mid-scale)
    • Sourced through catalog distributors such as Thermo Fisher (Alfa Aesar), TCI, Cayman, TRC, and MCE. These suppliers publish product pages with packaging, grades, and shipping availability.
  2. Commercial API demand (multi-kg to multi-ton)
    • Sourced via direct API manufacturers and contract manufacturing supply chains that provide batch documentation, CoA, and quality packages required for qualification.

Quality and documentation expectations (what buyers should require)

Fenofibric acid purchasers commonly require:

  • CoA per batch
  • Specification sheet (purity profile and typical impurities)
  • Analytical methods (often HPLC or related method packages)
  • Regulatory readiness for the intended market (e.g., DMF-supporting documentation when applicable)

These requirements determine which of the catalog distributors can qualify versus which vendors need to operate as true API suppliers with formal quality systems.

What to check in supplier screening (practical diligence points)

Procurement teams usually validate:

  • Manufacturing site capability for fenofibric acid and scale match (lab versus commercial)
  • Impurity profile control (critical because fenofibric acid is sensitive to manufacturing route and purification)
  • Packaging and labeling controls for transport and traceability
  • Change control history (source route and process changes can trigger requalification)

Key supplier list for fast sourcing (catalog + commercial channels)

Catalog / distributor supply (often fastest path for R&D)

  • Alfa Aesar (Thermo Fisher Scientific)
  • TCI Chemicals
  • Cayman Chemical
  • Toronto Research Chemicals (TRC)
  • MedChemExpress (MCE)

Commercial chemical/API suppliers (commonly used in API sourcing routes)

  • Aarti Industries

Key Takeaways

  • Fenofibric acid sourcing divides into catalog distributors for rapid R&D procurement and API manufacturers/CMOs for commercial qualification workflows.
  • The fastest frictionless sources for initial quantities are typical catalog suppliers (Alfa Aesar, TCI, Cayman, TRC, MCE).
  • For commercial supply, priority goes to API manufacturers such as Aarti Industries and vendors operating with pharma-grade documentation and impurity control.

FAQs

1) Who sells fenofibric acid in bulk through catalog channels?

Alfa Aesar (Thermo Fisher Scientific), TCI Chemicals, Cayman Chemical, TRC, and MedChemExpress list fenofibric acid for purchase through standard B2B catalog channels.

2) What is fenofibric acid’s CAS number used for supplier searches?

4465-29-4.

3) Do catalog suppliers provide pharma-grade API documentation?

Catalog distributors often provide CoA and standard chemical quality documentation, but pharma-grade and regulatory documentation readiness varies by vendor and product grade.

4) What supplier type is best for commercial API qualification?

Direct API manufacturers or contract manufacturers/CMOs with validated processes, impurity control, and batch documentation suitable for qualification.

5) What upstream factors most affect fenofibric acid lead times?

Availability of key upstream precursors and the capacity of purification/crystallization steps that control acid quality and impurity profile.


References

[1] Thermo Fisher Scientific. Alfa Aesar. Fenofibric acid product page.
[2] TCI Chemicals. Fenofibric acid product page.
[3] Cayman Chemical. Fenofibric acid product page.
[4] Toronto Research Chemicals. Fenofibric acid product page.
[5] MedChemExpress. Fenofibric acid product page.
[6] Aarti Industries. Fenofibric acid listing/product information (company catalog materials).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.